Text Size

Promoting Physical Activity for Persons With Multiple Sclerosis

This study has been completed.
Sponsor:
Collaborator:
Agency for Healthcare Research and Quality (AHRQ)
Information provided by:
University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:
NCT00513448
First received: August 7, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
  Purpose

The purpose of this study was to determine whether a group wellness intervention or individualized physical rehabilitation was more effective in improving health and physical activity in persons with multiple sclerosis.


Condition Intervention
Multiple Sclerosis
 Other: Group wellness intervention
Other: Individualized physical rehabilitation

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Health Services Research
Official Title: Comparing Individualized Rehabilitation to a Group Wellness Intervention for Persons With Multiple Sclerosis

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Minnesota - Clinical and Translational Science Institute:

Primary Outcome Measures:
  • Modified Fatigue Impact Scale SF-36 Mental Health Inventory [ Time Frame: 16 weeks ]

Secondary Outcome Measures:
  • Physical assessments [ Time Frame: 16-weeks ]

Enrollment: 50
Study Start Date: April 2005
Study Completion Date: November 2005
Detailed Description:

Evidence from this study shows that both interventions were effective in improving health and physical activity in persons with multiple sclerosis. The results also show that participants may benefit more physically from individualized physical rehabilitation and more mentally from group wellness interventions. Interventions that combine individualized therapeutic exercise with group health education might be most effective for persons with multiple sclerosis.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • A physician-confirmed diagnosis of MS
  • Between the ages of 18 to 75 years
  • Ability to ambulate 25 meters with or without the use of an adaptive aide

Exclusion Criteria:

  • Pregnant
  • Cardiovascular disease
  • Had fallen more than twice in the past month
  • Significant cognitive deficits
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00513448

Locations
United States, Minnesota
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Sponsors and Collaborators
University of Minnesota - Clinical and Translational Science Institute
Agency for Healthcare Research and Quality (AHRQ)
Investigators
Principal Investigator: Matthew A Plow, PhD Brown University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00513448     History of Changes
Other Study ID Numbers: 0311M53442
Study First Received: August 7, 2007
Last Updated: August 7, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by University of Minnesota - Clinical and Translational Science Institute:
Chronic Disabling Condition
Comparative Evaluation
Physical Activity
Physical Therapy
Rehabilitation

Additional relevant MeSH terms:
Multiple Sclerosis
Sclerosis
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Nervous System Diseases
 Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on May 19, 2013